TY - JOUR
T1 - Computational methodologies in the exploration of marine natural product leads
AU - Pereira, Florbela
AU - Aires-de-Sousa, João
N1 - info:eu-repo/grantAgreement/FCT/5876/147218/PT#
Grant: SFRH/BPD/108237/2015.
POCI-01-0145-FEDER-007265.
PY - 2018/7/13
Y1 - 2018/7/13
N2 - Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure–Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review.
AB - Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure–Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review.
KW - Bioinformatics
KW - Chemoinformatics
KW - Computer-aided drug design (CADD)
KW - Drug discovery
KW - Machine learning (ML)
KW - Marine natural products (MNPs)
UR - http://www.scopus.com/inward/record.url?scp=85052017748&partnerID=8YFLogxK
U2 - 10.3390/md16070236
DO - 10.3390/md16070236
M3 - Review article
C2 - 30011882
AN - SCOPUS:85052017748
VL - 16
JO - Marine Drugs
JF - Marine Drugs
IS - 7
M1 - 236
ER -